PERSONALITY OF HEALTHY-VOLUNTEERS PARTICIPATING IN PHASE-I CLINICAL-TRIALS

被引：14
|
作者：
CAMI, J
LLORENTE, M
FARRE, M
BADENAS, JM
机构：
来源：
PERSONALITY AND INDIVIDUAL DIFFERENCES | 1989年 / 10卷 / 11期
关键词：
D O I：
10.1016/0191-8869(89)90088-3
中图分类号：
B84 [心理学];
学科分类号：
04 ; 0402 ;
摘要：
引用
收藏
页码：1199 / 1200
页数：2
相关论文
共 50 条
  • [41] USING TOXICITY GRADES IN THE DESIGN AND ANALYSIS OF CANCER PHASE-I CLINICAL-TRIALS
    GORDON, NH
    WILLSON, JKV
    STATISTICS IN MEDICINE, 1992, 11 (16) : 2063 - 2075
  • [42] DOSE-FINDING AND TOLERABILITY STUDY OF MEDETOMIDINE IN 4 HEALTHY-VOLUNTEERS - AN OPEN PHASE-I INVESTIGATION
    SCHEININ, M
    KALLIO, A
    KOULU, M
    ARSTILA, M
    VIIKARI, J
    SCHEININ, H
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1987, 41 (05): : 637 - 646
  • [43] BIOLOGIC EFFECTS AND SAFETY OF STAVUDINE - OVERVIEW OF PHASE-I AND PHASE-II CLINICAL-TRIALS
    SKOWRON, G
    JOURNAL OF INFECTIOUS DISEASES, 1995, 171 : S113 - S117
  • [44] DRUG TRIALS ON HEALTHY-VOLUNTEERS IN YUGOSLAVIA
    VRHOVAC, R
    FRANCETIC, I
    ROTIM, K
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1990, 28 (09) : 375 - 379
  • [45] CLINICAL ASPECTS OF PHASE-I TRIALS
    CALVERT, AH
    BRITISH JOURNAL OF CANCER, 1985, 52 (03) : 412 - 412
  • [46] DETERMINATION OF A POTENTIAL ANTIASTHMATIC COMPOUND, TIBENELAST, AND ITS APPLICATION TO PHASE-I CLINICAL-TRIALS
    PEYTON, AL
    ZIEGE, EA
    JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1990, 529 (02): : 377 - 387
  • [47] Healthy Volunteers' Perceptions of the Benefits of Their Participation in Phase I Clinical Trials
    Fisher, Jill A.
    McManus, Lisa
    Wood, Megan M.
    Cottingham, Marci D.
    Kalbaugh, Julianne M.
    Monahan, Torin
    Walker, Rebecca L.
    JOURNAL OF EMPIRICAL RESEARCH ON HUMAN RESEARCH ETHICS, 2018, 13 (05) : 494 - 510
  • [48] PHARMACOLOGICALLY GUIDED PHASE-I CLINICAL-TRIALS BASED UPON PRECLINICAL DRUG DEVELOPMENT
    COLLINS, JM
    GRIESHABER, CK
    CHABNER, BA
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (16): : 1321 - 1326
  • [49] THE ROLE OF AN INITIAL SINGLE-BLIND PLACEBO PERIOD IN PHASE-I CLINICAL-TRIALS
    NONY, P
    BOISSEL, JP
    GIRARD, P
    LION, L
    HAUGH, MC
    FAREH, S
    DEBREYNE, B
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1994, 8 (02) : 185 - 187
  • [50] WHICH EXPERIMENTAL-DESIGN FOR PHASE-I CLINICAL-TRIALS - PROPOSAL FOR AN INVESTIGATIONAL APPROACH
    DURIEU, I
    GIRARD, P
    BOISSEL, JP
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1990, 4 : S77 - S80
12345